GB9810181D0
(en)
*
|
1998-05-13 |
1998-07-08 |
Smithkline Beecham Plc |
Novel formulations
|
CZ300647B6
(en)
*
|
1998-08-21 |
2009-07-08 |
Novartis Ag |
Solid pharmaceutical composition for peroral administration comprising tegaserod or pharmaceutically acceptable salt thereof
|
US7815937B2
(en)
*
|
1998-10-27 |
2010-10-19 |
Biovail Laboratories International Srl |
Quick dissolve compositions and tablets based thereon
|
CA2349203C
(en)
*
|
1998-11-20 |
2013-05-21 |
Rtp Pharma Inc. |
Dispersible phospholipid stabilized microparticles
|
US7223416B2
(en)
*
|
1999-06-28 |
2007-05-29 |
Minu, L.L.C. |
Topical composition
|
FR2795962B1
(en)
*
|
1999-07-08 |
2003-05-09 |
Prographarm Laboratoires |
PROCESS FOR THE MANUFACTURE OF MASK TASTE COATED GRANULES AND IMMEDIATE RELEASE OF THE ACTIVE INGREDIENT
|
IT1313589B1
(en)
*
|
1999-08-03 |
2002-09-09 |
Formenti Farmaceutici Spa |
PARACETAMOL CONTROLLED RELEASE COMPOSITIONS.
|
GB0003232D0
(en)
*
|
2000-02-11 |
2000-04-05 |
Smithkline Beecham Plc |
Novel composition
|
CA2311734C
(en)
|
2000-04-12 |
2011-03-08 |
Bristol-Myers Squibb Company |
Flash-melt oral dosage formulation
|
US20020022058A1
(en)
*
|
2000-07-08 |
2002-02-21 |
Lovercheck Dale R. |
Unit dose of material in system and method
|
US8586094B2
(en)
*
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
AU2001286237A1
(en)
*
|
2000-09-22 |
2002-04-02 |
Sumitomo Pharmaceuticals Company, Limited |
Oral preparations with favorable disintegration characteristics
|
ATE541564T1
(en)
*
|
2000-12-07 |
2012-02-15 |
Nycomed Gmbh |
QUICKLY DISRUPTING TABLET WITH AN ACID LABEL ACTIVE INGREDIENT
|
WO2002049607A2
(en)
*
|
2000-12-20 |
2002-06-27 |
Firmenich Sa |
Flavoured oral drug delivery system
|
US20030060451A1
(en)
*
|
2001-05-29 |
2003-03-27 |
Rajneesh Taneja |
Enhancement of oral bioavailability of non-emulsified formulations of prodrug esters with lecithin
|
US7255876B2
(en)
|
2001-07-27 |
2007-08-14 |
Astellas Pharma, Inc. |
Composition comprises sustained-release fine particles and manufacturing method thereof
|
US7838026B2
(en)
|
2001-09-28 |
2010-11-23 |
Mcneil-Ppc, Inc. |
Burst-release polymer composition and dosage forms comprising the same
|
US6982094B2
(en)
*
|
2001-09-28 |
2006-01-03 |
Mcneil-Ppc, Inc. |
Systems, methods and apparatuses for manufacturing dosage forms
|
US7323192B2
(en)
*
|
2001-09-28 |
2008-01-29 |
Mcneil-Ppc, Inc. |
Immediate release tablet
|
BR0206062A
(en)
|
2001-09-28 |
2004-01-13 |
Mcneil Ppc Inc |
Dosage forms having an inner core and outer shell
|
US7122143B2
(en)
|
2001-09-28 |
2006-10-17 |
Mcneil-Ppc, Inc. |
Methods for manufacturing dosage forms
|
US6610266B2
(en)
|
2001-11-28 |
2003-08-26 |
Michael C. Withiam |
Calcium metasilicates and methods for making
|
US6941948B2
(en)
*
|
2002-03-07 |
2005-09-13 |
Vectura Drug Delivery |
Medicament storage and delivery devices
|
US7807197B2
(en)
|
2002-09-28 |
2010-10-05 |
Mcneil-Ppc, Inc. |
Composite dosage forms having an inlaid portion
|
JP3444874B1
(en)
*
|
2002-12-02 |
2003-09-08 |
高砂香料工業株式会社 |
Granular fragrance and method for producing the same
|
US20040109889A1
(en)
|
2002-12-04 |
2004-06-10 |
Bunick Frank J. |
Surface treatment composition for soft substrates
|
US20040146553A1
(en)
*
|
2002-12-23 |
2004-07-29 |
Aventis Pharma S.A. |
Compositions for oral administration of active principles requiring masking of taste
|
FR2848855B1
(en)
*
|
2002-12-23 |
2005-02-11 |
Aventis Pharma Sa |
COMPOSITIONS FOR ORAL ADMINISTRATION OF ACTIVE INGREDIENTS REQUIRING TASTE MASKING
|
CN100415269C
(en)
*
|
2002-12-30 |
2008-09-03 |
毛友昌 |
Method for preparing cow-bezoar snake bile Sichuan fritillary bulb dispersive tablet
|
CN1303979C
(en)
*
|
2003-03-21 |
2007-03-14 |
毛友昌 |
Preparation of snake gallbladder and tangerine peel dispersed tablets
|
WO2004087096A1
(en)
*
|
2003-04-02 |
2004-10-14 |
Pliva-Istrazivanje I Razvoj D.O.O. |
Pharmaceutical compositions having reduced bitter taste
|
WO2004091582A1
(en)
*
|
2003-04-17 |
2004-10-28 |
Ipca Laboratories Limited |
Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them
|
FR2858556B1
(en)
*
|
2003-08-06 |
2006-03-10 |
Galenix Innovations |
DISPERSIBLE AND / OR ORODISPERSIBLE SOLID PHARMACEUTICAL COMPOSITION, NOT PELLETIZED, CONTAINING AT LEAST THE METFORMIN ACTIVE INGREDIENT, AND PROCESS FOR PREPARING THE SAME
|
US7282217B1
(en)
*
|
2003-08-29 |
2007-10-16 |
Kv Pharmaceutical Company |
Rapidly disintegrable tablets
|
US7459502B2
(en)
*
|
2003-11-03 |
2008-12-02 |
Ilypsa, Inc. |
Pharmaceutical compositions comprising crosslinked polyamine polymers
|
US7608674B2
(en)
|
2003-11-03 |
2009-10-27 |
Ilypsa, Inc. |
Pharmaceutical compositions comprising cross-linked small molecule amine polymers
|
US7335795B2
(en)
|
2004-03-22 |
2008-02-26 |
Ilypsa, Inc. |
Crosslinked amine polymers
|
US7767768B2
(en)
*
|
2003-11-03 |
2010-08-03 |
Ilypsa, Inc. |
Crosslinked amine polymers
|
US7385012B2
(en)
*
|
2003-11-03 |
2008-06-10 |
Ilypsa, Inc. |
Polyamine polymers
|
US7449605B2
(en)
*
|
2003-11-03 |
2008-11-11 |
Ilypsa, Inc. |
Crosslinked amine polymers
|
TW200524541A
(en)
*
|
2003-11-17 |
2005-08-01 |
Cargill Inc |
Lecithin-containing granular compositions and methods of their preparation
|
GB2411355B
(en)
|
2004-02-27 |
2006-02-22 |
Niche Generics Ltd |
Pharmaceutical composition
|
US8337887B2
(en)
*
|
2004-03-11 |
2012-12-25 |
Laboratories Pharmaceutiques Rodael |
Rapidly disintegrating taste-masked tablet
|
CN102133196B
(en)
|
2004-03-30 |
2015-01-21 |
瑞立普萨公司 |
Ion binding polymers
|
PL1732523T3
(en)
|
2004-03-30 |
2010-08-31 |
Vifor Pharma Tech Ltd |
Potassium binding polymers and uses thereof
|
WO2005104868A1
(en)
*
|
2004-04-30 |
2005-11-10 |
Bio Science Co., Ltd. |
Feed additive composition for ruminant, feed containing the same and process for producing feed additive composition for ruminant
|
AU2005247060C1
(en)
*
|
2004-05-24 |
2011-03-31 |
Takeda As |
Particulate comprising a calcium-containing compound and a sugar alcohol
|
KR100893847B1
(en)
*
|
2004-06-01 |
2009-04-17 |
니코메드 파마 에이에스 |
Chewable, suckable and swallowable tablet containing a caicium-containing compound as an active substance
|
PL1750862T3
(en)
|
2004-06-04 |
2011-06-30 |
Teva Pharma |
Pharmaceutical composition containing irbesartan
|
US20060024370A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Cephalon France |
Modafinil oral lyophilizate
|
US20060024335A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Roger Stier E |
Oral compositions which mask the bitter taste of a bitter-tasting agent
|
ES2255429B1
(en)
*
|
2004-10-25 |
2007-08-16 |
Italfarmaco, S.A. |
COMPOSITIONS PHARMACEUTICAL BUCODISPERSABLES.
|
ITMI20042356A1
(en)
*
|
2004-12-10 |
2005-03-10 |
Acraf |
ORODISPERSIBLE PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR PREPARING IT
|
US8673352B2
(en)
|
2005-04-15 |
2014-03-18 |
Mcneil-Ppc, Inc. |
Modified release dosage form
|
US20060252745A1
(en)
|
2005-05-06 |
2006-11-09 |
Almeida Jose L D |
Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
|
US20060263429A1
(en)
|
2005-05-20 |
2006-11-23 |
Hengsheng Feng |
Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof
|
CN101321519A
(en)
|
2005-09-30 |
2008-12-10 |
伊立普萨公司 |
Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
|
DE112006002618T5
(en)
|
2005-09-30 |
2008-08-28 |
Ilypsa Inc., Santa Clara |
Methods and compositions for selectively removing potassium ions from the mammalian gastrointestinal tract
|
US8906411B2
(en)
*
|
2005-12-07 |
2014-12-09 |
Takeda Nycomed As |
Pre-compacted calcium-containing compositions
|
UA95093C2
(en)
*
|
2005-12-07 |
2011-07-11 |
Нікомед Фарма Ас |
Method for the preparation of calcium-containing compound
|
FR2898492B1
(en)
*
|
2006-03-15 |
2008-06-06 |
Pierre Fabre Medicament Sa |
ORODISPERSIBLE TABLETS OF DOMPERIDONE
|
US20080014228A1
(en)
*
|
2006-07-14 |
2008-01-17 |
Olivia Darmuzey |
Solid form
|
CN100502842C
(en)
*
|
2006-08-31 |
2009-06-24 |
山东益康药业有限公司 |
Dispersing tablets of nizatidine, and its preparation method
|
EP1952803A1
(en)
|
2007-01-23 |
2008-08-06 |
KTB-Tumorforschungs GmbH |
Solid pharmaceutical dosage form containing hydrogenated phospholipids
|
WO2008104996A2
(en)
*
|
2007-02-28 |
2008-09-04 |
Jubilant Organosys Limited |
Water dispersible pharmaceutical formulation and process for preparing the same
|
US20080311162A1
(en)
*
|
2007-05-16 |
2008-12-18 |
Olivia Darmuzey |
Solid form
|
JP2008297277A
(en)
*
|
2007-06-01 |
2008-12-11 |
Taiyo Yakuhin Kogyo Kk |
Method for stabilizing parenteral injection
|
US8372431B2
(en)
|
2007-10-26 |
2013-02-12 |
Bial-Portela & C.A., S.A. |
Pharmaceutical composition comprising licarbazepine acetate
|
TWI592159B
(en)
|
2007-11-16 |
2017-07-21 |
威佛(國際)股份有限公司 |
Pharmaceutical compositions
|
WO2009150665A1
(en)
*
|
2008-06-09 |
2009-12-17 |
Lupin Limited |
Orally disintegrating pharmaceutical compositions of escitalopram and salts thereof
|
CN102325468B
(en)
*
|
2009-01-23 |
2015-08-12 |
惠氏有限责任公司 |
It is the nutritious supplementary pharmaceutical of more than 50 years old individual raising vigor, immunity, eye and bone health
|
WO2011066428A1
(en)
*
|
2009-11-25 |
2011-06-03 |
Cargill, Incorporated |
Sweetener compositions and methods of making the same
|
AU2010325746B2
(en)
*
|
2009-12-02 |
2016-02-25 |
Adare Pharmaceuticals S.R.L. |
Fexofenadine microcapsules and compositions containing them
|
AU2011342368B2
(en)
|
2010-12-13 |
2016-11-17 |
Rite-Prep Pty Ltd |
Gastric and colonic formulations and methods for making and using them
|
US20120276199A1
(en)
*
|
2011-04-01 |
2012-11-01 |
Dr. Reddy's Laboratories Limited |
Taste masked pharmaceutical formulations
|
WO2013022948A1
(en)
|
2011-08-08 |
2013-02-14 |
The Coca-Cola Company |
Cell lines comprising endogenous taste receptors and their uses
|
DE102011115173A1
(en)
*
|
2011-08-12 |
2013-02-14 |
Ipc Process-Center Gmbh & Co. Kg |
Granule, useful as hot or cold drink, comprises caffeine and sucralose and Stevia/steviol glycoside and/or neohesperidin dihydrochalcone in an enclosed shell of a fat
|
WO2013175511A1
(en)
*
|
2012-05-24 |
2013-11-28 |
V.B. Medicare Pvt. Ltd. |
Taste masked pharmaceutical compositions
|
DK2877163T3
(en)
*
|
2012-07-27 |
2019-04-15 |
Redhill Biopharma Ltd |
FORMULATIONS AND PROCEDURES FOR THE PREPARATION OF FORMS FOR USING GAS DRAINAGE
|
CN104366313A
(en)
*
|
2013-08-15 |
2015-02-25 |
珠海市红旌发展有限公司 |
Sweet potato leaf chewable tablet
|
GEP20217308B
(en)
|
2015-06-18 |
2021-10-25 |
Estetra Sprl |
Orodispersible dosage unit containing an estetrol component
|
CU24504B1
(en)
|
2015-06-18 |
2021-04-07 |
Estetra Sprl |
ORODISPERSABLE DOSING UNIT CONTAINING A STETROL COMPONENT AND A PROCESS INCLUDING A GRANULATION STEP TO PREPARE THE SAME
|
KR20220144885A
(en)
|
2016-08-05 |
2022-10-27 |
에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 |
Method for the management of dysmenorrhea and menstrual pain
|
JP6145954B1
(en)
*
|
2016-09-06 |
2017-06-14 |
株式会社東洋新薬 |
Eating and drinking composition
|
US10632076B2
(en)
|
2016-11-18 |
2020-04-28 |
Fertin Pharma A/S |
Tablet comprising separate binder and erythritol
|
US10543205B2
(en)
|
2016-11-18 |
2020-01-28 |
Fertin Pharma A/S |
Oral delivery vehicle containing nicotine
|
TWI801561B
(en)
|
2018-04-19 |
2023-05-11 |
比利時商依思特拉私人有限責任公司 |
Compounds and their uses for alleviating menopause-associated symptoms
|
US11090263B2
(en)
|
2018-05-22 |
2021-08-17 |
Fertin Pharma A/S |
Tableted chewing gum suitable for active pharmaceutical ingredients
|
US20190350858A1
(en)
|
2018-05-17 |
2019-11-21 |
Fertin Pharma A/S |
Oral tablet for delivery of active ingredients to the gastrointestinal tract
|
US11096896B2
(en)
|
2018-05-17 |
2021-08-24 |
Fertin Pharma A/S |
Tablet dosage form for buccal absorption of active ingredients
|
US11096895B2
(en)
|
2018-05-17 |
2021-08-24 |
Fertin Pharma A/S |
Oral tablet suitable for active pharmaceutical ingredients
|
US11058633B2
(en)
|
2018-05-17 |
2021-07-13 |
Fertin Pharma A/S |
Disintegrating oral tablet suitable for active pharmaceutical ingredients
|
US11096894B2
(en)
|
2018-05-17 |
2021-08-24 |
Fertin Pharma A/S |
Oral tablet for induced saliva generation
|
US11052047B2
(en)
|
2018-05-17 |
2021-07-06 |
Fertin Pharma A/S |
Oral tablet suitable for fast release of active pharmaceutical ingredients
|
US11135157B2
(en)
|
2018-05-17 |
2021-10-05 |
Fertin Pharma A/S |
Oral tablet for delivery of active ingredients to the throat
|
US11058641B2
(en)
|
2018-05-17 |
2021-07-13 |
Fertin Pharma A/S |
Oral tablet for taste masking of active ingredients
|
US10925853B2
(en)
|
2019-04-17 |
2021-02-23 |
Nordiccan A/S |
Oral cannabinoid tablet
|
WO2023101951A1
(en)
*
|
2021-12-03 |
2023-06-08 |
Hercules Llc |
An organic chewable composition comprising certified organic ingredients, and process for preparing the same
|